Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study assesses overall survival associated with electronic patient-reported symptom monitoring vs usual care during routine cancer treatment.

Related collections

Author and article information

Journal

Journal ID (nlm-ta): JAMA

Journal ID (iso-abbrev): JAMA

Journal ID (pmc): JAMA

Title: JAMA

Publisher: American Medical Association

ISSN (Print): 0098-7484

ISSN (Electronic): 1538-3598

Publication date (Electronic): 4 June 2017

Publication date (Print): 11 July 2017

Publication date PMC-release: 4 December 2017

Volume: 318

Issue: 2

Pages: 197-198

Affiliations

[1 ]Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

[2 ]Associate Editor, JAMA

[3 ]Memorial Sloan Kettering Cancer Center, New York, New York

[4 ]Mayo Clinic, Scottsdale, Arizona

[5 ]American Society of Clinical Oncology, Alexandria, Virginia

[6 ]Dana-Farber/Harvard Cancer Center, Boston, Massachusetts

Author notes

Article Information

Corresponding Author: Ethan Basch, MD, Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, 170 Manning Dr, CB# 7305, Chapel Hill, NC 27599-7305 ( ebasch@ 123456med.unc.edu ).

Accepted for Publication: May 22, 2017.

Published Online: June 4, 2017. doi:10.1001/jama.2017.7156

Author Contributions: Dr Basch had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Basch, Dueck, Scher, Schrag.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Basch, Deal, Scher.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Deal, Dueck, Schrag.

Obtained funding: Kris.

Administrative, technical, or material support: Basch, Scher, Kris, Hudis, Schrag.

Supervision: Hudis, Schrag.

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Dr Scher reports receiving personal fees from Astellas, BIND Pharmaceuticals, Clovis Oncology, Merck, Roche, Asterias Biotherapeutics, WIRB-Copernicus Group, and Sanofi Aventis; nonfinancial support from Ferring Pharmaceuticals, Janssen Research and Development, Medivation, and Takeda Millennium; and grants from Medivation, Janssen, Illumina, and Innocrin Pharma. Dr Kris reports receiving personal fees from Genetech/Roche, AstraZeneca, and ARIAD. No other disclosures were reported.

Funding/Support: This trial was funded by the Conquer Cancer Foundation of the American Society of Clinical Oncology.

Role of the Funder/Sponsor: The Conquer Cancer Foundation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Trial Registration: clinicaltrials.gov: NCT00578006

Disclaimer: Drs Basch and Schrag, both JAMA associate editors, were not involved in the review of or decision to publish this letter.

Meeting Presentation: This article was presented at the annual American Society of Clinical Oncology meeting; June 4, 2017; Chicago, Illinois.

Additional Contributions: We thank Lauren Rogak, MA, Laura Sit, MA, Thomas Atkinson, PhD, Dorothy Dulko, RN, PhD, and Paul Sabbatini, MD (all from Memorial Sloan Kettering Cancer Center); Allison Barz, MD (Children’s Hospital of Pennsylvania); and Antonia Bennett, PhD (University of North Carolina), for their collaboration in the conduct and analysis of this study. No one received compensation for their contribution.

Article

Accession ID: PMC5817466 Pmcid ID: PMC5817466 Pmc-uid ID: 5817466 Publisher ID: jld170018

DOI: 10.1001/jama.2017.7156

PMC ID: 5817466

PubMed ID: 28586821

SO-VID: c2a31f74-380c-4903-90ca-6089974f24d4

History

Date received : 11 May 2017

Date: 19 May 2017

Date accepted : 22 May 2017

Funding

Funded by: Conquer Cancer Foundation

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.